Irisin — the future of ischemic stroke therapy?
, 1, 1, 2, 2
Abstract
Irisin is a recently discovered hormone, synthesized mainly by the muscles. Expression of irisin and its precursor named FNDC5 was also found in the heart, kidneys, liver, pancreas, adipose tissue, and brain including cortical neurons, hippocampus, cerebellum, hypothalamus, and spinal cord. The purpose of this study is to review the latest research on the properties of the irisin and its cytoprotective effect against neuronal damage and to draw attention to its possible clinical use in the treatment of stroke. Notch pathway activity increases after ischemic damage, stimulating the repair of the affected brain area. Irisin activates the Notch pathway which inhibits the activity of microglia, secretion of inflammatory factors, and finally leads to reduction of the brain edema. Studies revealed that irisin increases levels of brain-derived neurotrophic factor (BDNF), leading to enhancement of survival and migration of the neurons, and protecting nerve cells from damage during the ischemic stroke. It was also found that irisin maintains mitochondrial integrity, reduces oxidative stress, and exerts a protective effect on the blood-brain barrier. Irisin entails a neuroprotective effect, reducing the extent of the infarcted area and the degree of brain damage. Stimulation of the irisin expression by physical activity or its exogenous administration remains the subject of research that raises hope for development of the new therapeutic options for diseases, especially ischemic stroke.
Keywords: ischemic strokeirisinapoptosisFNDC5 proteinBDNFblood-brain barrierbrain injuryneuroprotectionexercise
References
- Epidemiology of stroke. Excellence in stroke prevention&treatment. Boehringer Ingelheim Available online: https://pro boehringer-ingelheim com/strokeforum/overview/epidemiology. (assessed on 29 August 2022).
- Wilkins E, Wilson L, Wickramasinghe K, et al. European Cardiovascular Disease Statistics 2017. Eur Heart Netw Eur Soc Cardiol. Available online: https://ehnheart org/images/CVD-statistics-report-August-2017 pdf. (assessed on 29 August 2022).
- Putaala J. Ischemic Stroke in Young Adults. Continuum (Minneap Minn). 2020; 26(2): 386–414.
- Stack CA, Cole JW. Ischemic stroke in young adults. Curr Opin Cardiol. 2018; 33(6): 594–604.
- Colaianni G, Cinti S, Colucci S, et al. Irisin and musculoskeletal health. Ann N Y Acad Sci. 2017; 1402(1): 5–9.
- Byun K, Lee S. The Potential Role of Irisin in Vascular Function and Atherosclerosis: A Review. Int J Mol Sci. 2020; 21(19).
- Arhire LI, Mihalache L, Covasa M. Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome. Front Endocrinol (Lausanne). 2019; 10: 524.
- Jiang X, Cai S, Jin Y, et al. Irisin Attenuates Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in the H9C2 Cellular Model of Septic Cardiomyopathy through Augmenting Fundc1-Dependent Mitophagy. Oxid Med Cell Longev. 2021; 2021: 2989974.
- Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481(7382): 463–468.
- Waseem R, Shamsi A, Mohammad T, et al. FNDC5/Irisin: Physiology and Pathophysiology. Molecules. 2022; 27(3).
- Jin Z, Guo P, Li X, et al. Neuroprotective effects of irisin against cerebral ischemia/ reperfusion injury via Notch signaling pathway. Biomed Pharmacother. 2019; 120: 109452.
- Uzdensky AB. Apoptosis regulation in the penumbra after ischemic stroke: expression of pro- and antiapoptotic proteins. Apoptosis. 2019; 24(9-10): 687–702.
- Choudhary GS, Al-Harbi S, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol. 2015; 1219: 1–9.
- He R, Jiang Y, Shi Y, et al. Curcumin-laden exosomes target ischemic brain tissue and alleviate cerebral ischemia-reperfusion injury by inhibiting ROS-mediated mitochondrial apoptosis. Mater Sci Eng C Mater Biol Appl. 2020; 117: 111314.
- Guo P, Jin Z, Wang J, et al. Irisin Rescues Blood-Brain Barrier Permeability following Traumatic Brain Injury and Contributes to the Neuroprotection of Exercise in Traumatic Brain Injury. Oxid Med Cell Longev. 2021; 2021: 1118981.
- Fan LF, He PY, Peng YC, et al. Mdivi-1 ameliorates early brain injury after subarachnoid hemorrhage via the suppression of inflammation-related blood-brain barrier disruption and endoplasmic reticulum stress-based apoptosis. Free Radic Biol Med. 2017; 112: 336–349.
- Ježek P, Holendová B, Garlid KD, et al. Mitochondrial Uncoupling Proteins: Subtle Regulators of Cellular Redox Signaling. Antioxid Redox Signal. 2018; 29(7): 667–714.
- Budni J, Bellettini-Santos T, Mina F, et al. The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease. Aging Dis. 2015; 6(5): 331–341.
- Liu Y, Zhu C, Guo J, et al. The Neuroprotective Effect of Irisin in Ischemic Stroke. Front Aging Neurosci. 2020; 12: 588958.
- Wrann CD, White JP, Salogiannnis J, et al. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab. 2013; 18(5): 649–659.
- Asadi Y, Gorjipour F, Behrouzifar S, et al. Irisin Peptide Protects Brain Against Ischemic Injury Through Reducing Apoptosis and Enhancing BDNF in a Rodent Model of Stroke. Neurochem Res. 2018; 43(8): 1549–1560.
- Raefsky SM, Mattson MP. Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance. Free Radic Biol Med. 2017; 102: 203–216.
- Jiang S, Li T, Ji T, et al. AMPK: Potential Therapeutic Target for Ischemic Stroke. Theranostics. 2018; 8(16): 4535–4551.
- Fan J, Zhu Q, Wu Z, et al. Protective effects of irisin on hypoxia-reoxygenation injury in hyperglycemia-treated cardiomyocytes: Role of AMPK pathway and mitochondrial protection. J Cell Physiol. 2020; 235(2): 1165–1174.
- Zhang R, Ji J, Zhou X, et al. Irisin Pretreatment Protects Kidneys against Acute Kidney Injury Induced by Ischemia/Reperfusion via Upregulating the Expression of Uncoupling Protein 2. Biomed Res Int. 2020; 2020: 6537371.
- Fujimura M, Gasche Y, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res. 1999; 842(1): 92–100.
- Kamada H, Yu F, Nito C, et al. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction. Stroke. 2007; 38(3): 1044–1049.
- Guo P, Jin Z, Wu H, et al. Effects of irisin on the dysfunction of blood-brain barrier in rats after focal cerebral ischemia/reperfusion. Brain Behav. 2019; 9(10): e01425.
- Tu WJ, Qiu HC, Cao JL, et al. Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke. Neurotherapeutics. 2018; 15(4): 1158–1167.
- Wu H, Guo P, Jin Z, et al. Serum levels of irisin predict short-term outcomes in ischemic stroke. Cytokine. 2019; 122: 154303.
- Di Raimondo D, Rizzo G, Musiari G, et al. Role of Regular Physical Activity in Neuroprotection against Acute Ischemia. Int J Mol Sci. 2020; 21(23).
- Bullitt E, Rahman FN, Smith JK, et al. The effect of exercise on the cerebral vasculature of healthy aged subjects as visualized by MR angiography. AJNR Am J Neuroradiol. 2009; 30(10): 1857–1863.
- Otsuka S, Sakakima H, Sumizono M, et al. The neuroprotective effects of preconditioning exercise on brain damage and neurotrophic factors after focal brain ischemia in rats. Behav Brain Res. 2016; 303: 9–18.
- Sakakima H. Endogenous neuroprotective potential due to preconditioning exercise in stroke. Phys Ther Res. 2019; 22(2): 45–52.
- Stephan JS, Sleiman SF. Exercise Factors Released by the Liver, Muscle, and Bones Have Promising Therapeutic Potential for Stroke. Front Neurol. 2021; 12: 600365.
- Zhang Y, Zhang X, Lin S. Irisin: A bridge between exercise and neurological diseases. Heliyon. 2022; 8(12): e12352.